Managing possible antibiotic allergy in children

Jean-Christoph Caubet1, Philippe A Eigenmann

  • 1Department of Child and Adolescent, University Hospitals of Geneva, Medical School of the University of Geneva, Geneva, Switzerland. Jean-Christoph.Caubet@hcuge.ch

Insights

Antibiotic allergy in children is frequently overdiagnosed. Accurate diagnosis through allergy workup, including challenge tests, is crucial to prevent severe reactions and avoid unnecessary drug restrictions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Public Health

Background:

  • Antibiotic allergy is rare in children but often overdiagnosed, posing a significant public health concern.
  • Overdiagnosis leads to unnecessary avoidance of essential antibiotics, contributing to antimicrobial resistance and increased healthcare costs.

Purpose of the Study:

  • To review the current literature on the diagnosis and management of suspected antibiotic allergy in pediatric patients.
  • To emphasize the importance of accurate diagnostic strategies to differentiate true allergies from non-allergic reactions.

Main Methods:

  • Review of recent scientific literature focusing on antibiotic allergy diagnosis in children.
  • Analysis of diagnostic approaches, including patient history, allergy workup, and specific testing methods.

Main Results:

  • Patient history is critical but insufficient for diagnosing antibiotic allergy; referral to an allergist is recommended.
  • Diagnostic workup involves carefully selected tests based on reaction type (immediate vs. non-immediate), with antigen challenge tests as the gold standard.
  • New diagnostic tools are under investigation and show promising results, potentially improving accuracy and safety.

Conclusions:

  • Accurate diagnosis of antibiotic allergy is vital to prevent severe, life-threatening reactions.
  • Avoiding unnecessary drug restrictions due to misdiagnosis is essential to combat antimicrobial resistance and reduce healthcare expenses.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...